Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1969 Sep;37(1):140–150. doi: 10.1111/j.1476-5381.1969.tb09531.x

A sequential screening test based on the running component of audiogenic seizures in mice, including reference compound PD50 values

A J Collins, M Horlington
PMCID: PMC1703797  PMID: 5824929

Abstract

1. The running component of audiogenic seizures in mice has been used as the basis of a sequential screening test for the detection of a variety of centrally acting drugs.

2. For acceptance by the test, an active compound must completely suppress the running component in a total of sixteen mice at a dose of 1/5 LD50 intraperitoneally.

3. Considerable economies in the numbers of animals required for screening have been achieved, the mean number of mice required to reject an inactive compound being 2·0.

4. The running component is highly sensitive to anticonvulsants and general central depressants, and insensitive to phenothiazine tranquillizers and morphine. Reserpine caused an increase in the severity of the running component.

5. The statistical model used in this test is of general application to screening test situations which use quantal data.

Full text

PDF
140

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEVAN W. Sound-precipitated convulsions: 1947 to 1954. Psychol Bull. 1955 Nov;52(6):473–504. doi: 10.1037/h0044568. [DOI] [PubMed] [Google Scholar]
  2. CHEN G., WESTON J. K., BRATTON A. C., Jr Anticonvulsant activity and toxicity of phensuximide, methsuximide and ethosuximide. Epilepsia. 1963 Mar;4:66–76. doi: 10.1111/j.1528-1157.1963.tb05209.x. [DOI] [PubMed] [Google Scholar]
  3. FINK G. B., SWINYARD E. A. Effects of psychopharmacologic agents on experimentally-induced seizures in mice. J Am Pharm Assoc Am Pharm Assoc. 1960 Aug;49:510–513. [PubMed] [Google Scholar]
  4. FINK G. B., SWINYARD E. A. Modification of maximal audiogenic and electroshock seizures in mice by psychopharmacologic drugs. J Pharmacol Exp Ther. 1959 Dec;127:318–324. [PubMed] [Google Scholar]
  5. PLOTNIKOFF N. P. Bioassay of potential tranquilizers and sedatives against audiogenic seizures in mice. Arch Int Pharmacodyn Ther. 1958 Aug 1;116(1-2):130–135. [PubMed] [Google Scholar]
  6. PLOTNIKOFF N. P. EFFECT OF PSYCHOACTIVE DRUGS ON ESCAPE FROM AUDIOGENIC SEIZURES. Arch Int Pharmacodyn Ther. 1963 Oct 1;145:413–420. [PubMed] [Google Scholar]
  7. PLOTNIKOFF N. Ataractics and strain differences in audiogenic seizures in mice. Psychopharmacologia. 1960 Sep 13;1:429–432. doi: 10.1007/BF00441190. [DOI] [PubMed] [Google Scholar]
  8. RILEY H., SPINKS A. Biological assessment of tranquillisers. I. J Pharm Pharmacol. 1958 Nov;10(11):657–671. doi: 10.1111/j.2042-7158.1958.tb10358.x. [DOI] [PubMed] [Google Scholar]
  9. SWINYARD E. A., CASTELLION A. W., FINK G. B., GOODMAN L. S. Some neurophysiological and neuropharmacological characteristics of audiogenic-seizure-susceptible mice. J Pharmacol Exp Ther. 1963 Jun;140:375–384. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES